PAMA - G2 Intelligence

Reintroduction of SALSA Revives Labs’ Hopes for PAMA Relief

New legislation would force CMS to change the way it calculates Medicare prices for lab tests.

An overview of PAMA and key aspects lab compliance officers should be aware of to help ensure compliance.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Even though PAMA has slashed reimbursement rates for many tests, overall Medicare Part B spending on lab tests continues to increase.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Legislation offering permanent relief from both PAMA price cuts and reporting didn’t make it into the federal spending bill passed Dec. 23.

Start a Free Trial for immediate access to this article

Already a member? Log in here

Though the federal spending bill passed at the end of December offers another year’s reprieve from PAMA price cuts, SALSA was not included.